Thermo Fisher stock gains support from Q2 growth and upcoming ex-dividend date

Thermo Fisher Scientific Inc. stock (ISIN US8835561023) is trading near recent analyst target levels after stronger second-quarter 2026 results and an upcoming ex-dividend date of September 15, 2026, drawing renewed attention from investors.

Q2 2026 results underpin Thermo Fisher stock

According to Choicestock on July 23, 2026, Thermo Fisher Scientific reported second-quarter 2026 revenue of USD 11.99 billion, exceeding market expectations and signaling solid demand across its laboratory products, diagnostics, and bioprocessing businesses.

The same Q2 2026 update showed non-GAAP earnings per share of USD 6.03, with analysts highlighting that this performance came in above consensus and helped restore confidence in the company’s margin profile.Choicestock

Guidance for full-year 2026 was described as pointing to revenue of USD 47.76 billion, implying year-on-year growth of 7.19 percent compared with the prior year, and projected non-GAAP EPS of USD 19.97, up 12.57 percent versus the previous fiscal year.Choicestock

Analyst targets and market reaction

A recent performance review from July 23, 2026 noted that Thermo Fisher stock moved up by 9.89 percent on that day after the Q2 2026 earnings release, indicating a strong market reaction to the combination of earnings outperformance and improved outlook.TradingKey

As the same analysis summarized, multiple analysts maintained or initiated positive views on Thermo Fisher, with an average price target of USD 603.15, effectively aligning expectations with the upper end of the recent trading range.TradingKey

For investors, the combination of high-single-digit expected revenue growth and double-digit projected EPS expansion in 2026, together with supportive analyst targets around USD 603, frames Thermo Fisher as a large-cap life science tools company positioned for gradual earnings acceleration rather than rapid cyclical swings.Choicestock

Ex-dividend date and shareholder returns

Income-focused shareholders have an additional near-term catalyst: Thermo Fisher stock is scheduled to trade ex-dividend on September 15, 2026, with a cash dividend of USD 0.47 per share payable on October 15, 2026 to holders of record on the ex-dividend date.Moomoo

While the absolute yield from a USD 0.47 quarterly dividend is modest in the context of Thermo Fisher’s market capitalization, the regular payout complements the company’s growth profile and can make the shares more attractive for investors who value a blend of capital appreciation and recurring cash returns.Moomoo

In addition, forecasts cited alongside the Q2 2026 update point to revenue expanding further to USD 50.32 billion in 2027 and USD 53.42 billion in 2028, with EPS projections of USD 22.74 in 2027 and USD 26.51 in 2028, suggesting continued room for dividend growth over time as earnings and cash flow scale.Choicestock

Share price, volatility and market cap

Per recent data for the Thermo Fisher Scientific ticker TMO on the New York Stock Exchange, the current price stands at USD 603.18, with a decline of 0.41 percent over the latest 24-hour period, indicating a relatively small pullback from the prior close in otherwise stable trading.TradingView

The same stock overview notes that Thermo Fisher’s share price has shown daily volatility around 1.99 percent and a beta of 0.68, meaning the stock tends to move less than the broader equity market, which can be appealing for investors seeking exposure to life sciences with somewhat reduced market sensitivity.TradingView

As of September 13, 2026, Thermo Fisher Scientific’s market capitalization was reported at INR 21.542 trillion in one currency-converted overview, underscoring its position among the world’s largest listed companies and ranking it around 82nd globally by market value.CompaniesMarketCap

Next earnings date and investor focus

Looking ahead, Thermo Fisher is expected to publish its next earnings report on October 28, 2026, a date that will provide updated insight into whether the company is tracking towards its full-year 2026 guidance and whether the growth in areas such as clinical research and diagnostic solutions remains robust.TradingView

For investors, key checkpoints in that upcoming release will likely include whether reported revenue growth stays in the mid-single- to high-single-digit range, whether non-GAAP EPS continues to expand at double-digit rates compared with the prior year, and how management updates its guidance for 2027 and 2028 in light of ongoing trends in bioprocessing, inventory normalization, and demand for advanced instruments.Choicestock

Thermo Fisher stock price as of the latest session

Thermo Fisher stock recently traded at USD 603.18 on the New York Stock Exchange, with the quote reflecting the latest completed trading session before September 14, 2026 and positioning the shares close to the average analyst target of USD 603.15 highlighted after the Q2 2026 earnings release.

More news and analyses on Thermo Fisher Scientific stock